News
Pharmaceutical Technology on MSN3d
Padcev-Keytruda combo approved for NHS use in mUC
The combination will now join Bristol Myers Squibb’s Opdivo in the list of bladder cancer drugs available on the NHS.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback